[Pancreas grafts. Nuclear medical perfusion to exclude vascular complications and rejection crises (author's transl)].
Perfusion studies with 99m Tc-DTPA, which has hitherto been used routinely to investigate renal grafts, have also proved useful for monitoring the perfusion of pancreas grafts. A total perfusion failure is equally reliably demonstrable as in renal grafts. Quantitatively smaller perfusion alterations can be demonstrated by monitoring the course. It seems possible to differentiate the salivary edema of a rejection reaction, well known from animal experiments, with the help of other parameters (e. g. creatinine). Further clinical studies are however necessary to confirm these results.
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D006084:Graft Rejection; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D010179:Pancreas / Q000098:blood supply; D016035:Pancreas Transplantation; D004369:Pentetic Acid; D011183:Postoperative Complications / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D013667:Technetium; D016284:Technetium Tc 99m Pentetate; D013927:Thrombosis / Q000000981:diagnostic imaging*
D001786:Blood Glucose; D013667:Technetium; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate
Pankreas-Transplantation. Nuklearmedizinische Perfusionsstudien zum Ausschluss von vaskulärewn Komplikationen und Abstossungskrisen.